DnB Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,444
| Closed | -$461K | – | 771 |
|
|
2025
Q1 | $461K | Sell |
10,444
-1,431
| -12% | -$63.2K | ﹤0.01% | 662 |
|
|
2024
Q4 | $429K | Sell |
11,875
-529
| -4% | -$19.1K | ﹤0.01% | 671 |
|
|
2024
Q3 | $397K | Buy |
12,404
+1,002
| +9% | +$32.1K | ﹤0.01% | 667 |
|
|
2024
Q2 | $429K | Buy |
11,402
+1,617
| +17% | +$60.9K | ﹤0.01% | 661 |
|
|
2024
Q1 | $482K | Sell |
9,785
-2,225
| -19% | -$110K | ﹤0.01% | 654 |
|
|
2023
Q4 | $438K | Buy |
12,010
+24
| +0.2% | +$876 | ﹤0.01% | 631 |
|
|
2023
Q3 | $277K | Sell |
11,986
-2,825
| -19% | -$65.3K | ﹤0.01% | 653 |
|
|
2023
Q2 | $388K | Buy |
14,811
+4,568
| +45% | +$120K | ﹤0.01% | 643 |
|
|
2023
Q1 | $264K | Buy |
10,243
+52
| +0.5% | +$1.34K | ﹤0.01% | 642 |
|
|
2022
Q4 | $265K | Buy |
+10,191
| New | +$265K | ﹤0.01% | 630 |
|